Objective To assess the frequency and associated characteristics of COVID‐19 vaccine
hesitancy among pregnant and postpartum individuals. Design Cross‐sectional study …

Background Poor representation of pregnant and lactating women and people in clinical
trials has marginalised their health concerns and denied the maternal–fetal/infant dyad …

In May 2023, the US FDA advisors endorsed Pfizer's pregnancy-administered vaccine
(branded ABRYSVO) to protect infants from respiratory syncytial virus (RSV) infection …

The emergence of the novel coronavirus disease 2019 (COVID-19) presented the field of
reproductive medicine with many challenges due to an absence of data to guide clinical …

Background There is suboptimal uptake of recommended maternal vaccines (pertussis and
influenza) during pregnancy in the UK. The Covid-19 pandemic has impacted healthcare …

Despite the important benefits of maternal vaccination for pregnant women and newborns,
vaccination uptake is low in many European countries. Differences in vaccination policies …

Since the first time the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
appeared and was first identified in late 2019 in Wuhan, China, it has caused tremendous …

Despite great need for improved understanding of the use of drugs and biological products
in pregnancy, clinical trials in pregnancy are rare, therapeutics in pregnancy are woefully …

The government of Pakistan started vaccination campaign for the frontline healthcare pro-
viders, as they are more likely to be exposed to COVID-19 patients. In the next step, it ex …

Women's physiological changes in pregnancy and breastfeeding may alter the
pharmacokinetics and the pharmacodynamics of many drugs, resulting in potential risks to …